참고문헌
- Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. The cell biology of bone metabolism. J Clin Pathol. 2008;61:577-587. https://doi.org/10.1136/jcp.2007.048868
- Charles JF, Aliprantis AO. Osteoclasts: more than 'bone eaters'. Trends Mol Med . 2014;20:449-459. https://doi.org/10.1016/j.molmed.2014.06.001
-
Erkhembaatar M, Gu DR, Lee SH, Yang YM, Park S, Muallem S, Shin DM, Kim MS. Lysosomal
$Ca^{2+}$ signaling is essential for osteoclastogenesis and bone remodeling. J Bone Miner Res. 2017;32:385-396. https://doi.org/10.1002/jbmr.2986 - Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746.
- Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504-1508. https://doi.org/10.1126/science.289.5484.1504
- Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13:1016-1023. https://doi.org/10.1038/ncb2329
- Jeyabalan J, Shah M, Viollet B, Chenu C. AMP-activated protein kinase pathway and bone metabolism. J Endocrinol. 2012;212:277-290. https://doi.org/10.1530/JOE-11-0306
- Lee YS, Kim YS, Lee SY, Kim GH, Kim BJ, Lee SH, Lee KU, Kim GS, Kim SW, Koh JM. AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts. Bone. 2010;47:926-937. https://doi.org/10.1016/j.bone.2010.08.001
- Ming W, Lu G, Xin S, Huanyu L, Yinghao J, Xiaoying L, Chengming X, Banjun R, Li W, Zifan L. Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation. Biochem Biophys Res Commun. 2016;476:412-419. https://doi.org/10.1016/j.bbrc.2016.05.135
- Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A. 2001;98:6336-6341. https://doi.org/10.1073/pnas.101133498
-
Qin Q, Jin J, He F, Zheng Y, Li T, Zhang Y, He J. Humanin promotes mitochondrial biogenesis in pancreatic MIN6
${\beta}$ -cells. Biochem Biophys Res Commun. 2018;497:292-297. https://doi.org/10.1016/j.bbrc.2018.02.071 - Lee C, Yen K, Cohen P. Humanin: a harbinger of mitochondrialderived peptides? Trends Endocrinol Metab. 2013;24:222-228. https://doi.org/10.1016/j.tem.2013.01.005
- Zhang Z, Welte T, Troiano N, Maher SE, Fu XY, Bothwell AL. Osteoporosis with increased osteoclastogenesis in hematopoietic cellspecific STAT3-deficient mice. Biochem Biophys Res Commun. 2005;328:800-807. https://doi.org/10.1016/j.bbrc.2005.01.019
- Gidlund EK, von Walden F, Venojarvi M, Riserus U, Heinonen OJ, Norrbom J, Sundberg CJ. Humanin skeletal muscle protein levels increase after resistance training in men with impaired glucose metabolism. Physiol Rep. 2016;4:e13063. https://doi.org/10.14814/phy2.13063
- Widmer RJ, Flammer AJ, Herrmann J, Rodriguez-Porcel M, Wan J, Cohen P, Lerman LO, Lerman A. Circulating humanin levels are associated with preserved coronary endothelial function. Am J Physiol Heart Circ Physiol. 2013;304:H393-H397. https://doi.org/10.1152/ajpheart.00765.2012
- Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 2005;106:852-859. https://doi.org/10.1182/blood-2004-09-3662
-
Kim MS, Yang YM, Son A, Tian YS, Lee SI, Kang SW, Muallem S, Shin DM. RANKL-mediated reactive oxygen species pathway that induces long lasting
$Ca^{2+}$ oscillations essential for osteoclastogenesis. J Biol Chem. 2010;285:6913-6921. https://doi.org/10.1074/jbc.M109.051557 - Sreekumar PG, Hinton DR, Kannan R. Endoplasmic reticulummitochondrial crosstalk: a novel role for the mitochondrial peptide humanin. Neural Regen Res. 2017;12:35-38. https://doi.org/10.4103/1673-5374.198970
- Liu X, Chhipa RR, Nakano I, Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther. 2014;13:596-605. https://doi.org/10.1158/1535-7163.MCT-13-0579
- Matsuoka M, Hashimoto Y. Humanin and the receptors for humanin. Mol Neurobiol. 2010;41:22-28. https://doi.org/10.1007/s12035-009-8090-z
- Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, Niikura T, Nishimoto I, Cohen P. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A. 2003;100:13042-13047. https://doi.org/10.1073/pnas.2135111100
-
Yang YM, Kim MS, Son A, Hong JH, Kim KH, Seo JT, Lee SI, Shin DM. Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from
$SERCA2^{+/-}$ mice. J Bone Miner Res. 2009;24:1763-1769. https://doi.org/10.1359/jbmr.090420 - Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337-342. https://doi.org/10.1038/nature01658
- Feng X, Teitelbaum SL. Osteoclasts: new insights. Bone Res. 2013;1:11-26. https://doi.org/10.4248/BR201301003
- Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab. 2000;18:344-349. https://doi.org/10.1007/s007740070007
- Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139-146. https://doi.org/10.1016/j.abb.2008.03.018
- Son A, Kim MS, Jo H, Byun HM, Shin DM. Effects of inositol 1,4,5-triphosphate on osteoclast differentiation in RANKL-induced osteoclastogenesis. Korean J Physiol Pharmacol. 2012;16:31-36. https://doi.org/10.4196/kjpp.2012.16.1.31
- Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889-901. https://doi.org/10.1016/S1534-5807(02)00369-6
- Park B, Yang YM, Choi BJ, Kim MS, Shin DM. Activation of G proteins by aluminum fluoride enhances RANKL-mediated osteoclastogenesis. Korean J Physiol Pharmacol. 2013;17:427-433. https://doi.org/10.4196/kjpp.2013.17.5.427
- Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21:233-241. https://doi.org/10.11005/jbm.2014.21.4.233
- Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 2007;282:15921-15929. https://doi.org/10.1074/jbc.M609723200
- Takayanagi H. The role of NFAT in osteoclast formation. Ann N Y Acad Sci. 2007;1116:227-237. https://doi.org/10.1196/annals.1402.071
- Saito Y, Chapple RH, Lin A, Kitano A, Nakada D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell. 2015;17:585-596. https://doi.org/10.1016/j.stem.2015.08.019
- Kim J, Yang G, Kim Y, Kim J, Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med. 2016;48:e224. https://doi.org/10.1038/emm.2016.16
- Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9:563-575. https://doi.org/10.1038/nrc2676
- Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8:774-785. https://doi.org/10.1038/nrm2249
- Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol. 2007;8:51. https://doi.org/10.1186/1471-2121-8-51
- Jang WG, Kim EJ, Bae IH, Lee KN, Kim YD, Kim DK, Kim SH, Lee CH, Franceschi RT, Choi HS, Koh JT. Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone. 2011;48:885-893. https://doi.org/10.1016/j.bone.2010.12.003
피인용 문헌
- Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases vol.264, 2019, https://doi.org/10.1016/j.lfs.2020.118679
- Isovaleric acid ameliorates ovariectomy‐induced osteoporosis by inhibiting osteoclast differentiation vol.25, pp.9, 2019, https://doi.org/10.1111/jcmm.16482